Literature DB >> 12975467

15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?

William S Powell1.   

Abstract

15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) affects gene transcription by activating PPARgamma and by covalent addition to transcription factors and signaling molecules, However, it is not known whether the high concentrations of 15d-PGJ2 required for these responses are consistent with physiological levels. A new study suggests that in vivo 15d-PGJ2 levels are actually several orders of magnitude below the levels required to induce many of the biological effects attributed to this molecule.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975467      PMCID: PMC193674          DOI: 10.1172/JCI19796

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Inducible cyclooxygenase may have anti-inflammatory properties.

Authors:  D W Gilroy; P R Colville-Nash; D Willis; J Chivers; M J Paul-Clark; D A Willoughby
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

2.  The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras.

Authors:  Jose Luis Oliva; Dolores Pérez-Sala; Antonio Castrillo; Natalia Martínez; F Javier Cañada; Lisardo Boscá; José M Rojas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

3.  Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells.

Authors:  H Bamba; S Ota; A Kato; C Kawamoto; K Fujiwara
Journal:  Biochem Biophys Res Commun       Date:  2000-07-05       Impact factor: 3.575

4.  PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation.

Authors:  A Chawla; Y Barak; L Nagy; D Liao; P Tontonoz; R M Evans
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

5.  15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes.

Authors:  Takahiro Shibata; Mitsuhiro Kondo; Toshihiko Osawa; Noriyuki Shibata; Makio Kobayashi; Koji Uchida
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

6.  Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.

Authors:  C E Clay; A M Namen; G Atsumi; A J Trimboli; A N Fonteh; K P High; F H Chilton
Journal:  J Investig Med       Date:  2001-09       Impact factor: 2.895

7.  15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

Authors:  D S Straus; G Pascual; M Li; J S Welch; M Ricote; C H Hsiang; L L Sengchanthalangsy; G Ghosh; C K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

8.  15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils.

Authors:  Guillaume Monneret; Hongping Li; Julian Vasilescu; Joshua Rokach; William S Powell
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 9.  PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer.

Authors:  G J Murphy; J C Holder
Journal:  Trends Pharmacol Sci       Date:  2000-12       Impact factor: 14.819

Review 10.  Emerging roles of PPARs in inflammation and immunity.

Authors:  Raymond A Daynes; Dallas C Jones
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

View more
  28 in total

1.  Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity.

Authors:  Philip Hallenborg; Claus Jørgensen; Rasmus K Petersen; Søren Feddersen; Pedro Araujo; Patrick Markt; Thierry Langer; Gerhard Furstenberger; Peter Krieg; Arjen Koppen; Eric Kalkhoven; Lise Madsen; Karsten Kristiansen
Journal:  Mol Cell Biol       Date:  2010-06-07       Impact factor: 4.272

2.  Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy.

Authors:  Anne R Diers; Brian P Dranka; Karina C Ricart; Joo Yeun Oh; Michelle S Johnson; Fen Zhou; Manuel A Pallero; Thomas M Bodenstine; Joanne E Murphy-Ullrich; Danny R Welch; Aimee Landar
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

Review 3.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

4.  Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells.

Authors:  Maria R Fernando; Mark A Giembycz; Derek M McKay
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

5.  COX2-derived primary and cyclopentenone prostaglandins are increased after asphyxial cardiac arrest.

Authors:  Hao Liu; Marie E Rose; Tricia M Miller; Wenjin Li; Sunita N Shinde; Alicia M Pickrell; Samuel M Poloyac; Steven H Graham; Robert W Hickey
Journal:  Brain Res       Date:  2013-04-24       Impact factor: 3.252

6.  Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function.

Authors:  James R Springstead; B Gabriel Gugiu; Sangderk Lee; Seung Cha; Andrew D Watson; Judith A Berliner
Journal:  J Lipid Res       Date:  2012-05-01       Impact factor: 5.922

Review 7.  Isoprostane generation and function.

Authors:  Ginger L Milne; Huiyong Yin; Klarissa D Hardy; Sean S Davies; L Jackson Roberts
Journal:  Chem Rev       Date:  2011-08-18       Impact factor: 60.622

Review 8.  Peroxisome proliferator-activated receptor gamma (PPARgamma) and colorectal carcinogenesis.

Authors:  Ioannis A Voutsadakis
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-21       Impact factor: 4.553

9.  Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis.

Authors:  Victoria A Blaho; Matthew W Buczynski; Charles R Brown; Edward A Dennis
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

Review 10.  Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology.

Authors:  Matthew W Buczynski; Darren S Dumlao; Edward A Dennis
Journal:  J Lipid Res       Date:  2009-02-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.